How to Interpret Phase II Data for Everolimus Plus Bevacizumab in Renal Cell Carcinoma

Title
How to Interpret Phase II Data for Everolimus Plus Bevacizumab in Renal Cell Carcinoma
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 28, Issue 13, Pages 2125-2126
Publisher
American Society of Clinical Oncology (ASCO)
Online
2010-04-06
DOI
10.1200/jco.2009.27.4951

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started